US Broker Ratings

Amgen Inc. (AMGN) Investor Outlook: Evaluating a Solid Healthcare Player with Limited Upside Potential

Amgen Inc. (NASDAQ: AMGN), a heavyweight in the healthcare sector, stands as a formidable player among drug manufacturers, boasting a substantial market capitalization of $188.01 billion...

Incyte Corporation (INCY) Stock Analysis: Exploring a Potential 18% Upside in the Biotechnology Sector

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is currently attracting attention from investors due to its robust growth potential and a promising..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 44% Potential Upside with Strong Buy Ratings

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust performance and promising growth trajectory. Based..

Medtronic plc (MDT): Investor Outlook Highlights 27% Potential Upside

Medtronic plc (NYSE: MDT) is a giant in the healthcare sector, specifically within the medical devices industry, with a commanding market capitalization of $111.88 billion. Headquartered..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 12.4% Upside in a Volatile Market

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare plans industry, presents an intriguing opportunity for investors despite a recent dip in its stock..

Mettler-Toledo International (MTD) Stock Analysis: Potential Upside Amidst Strong Revenue Growth

Mettler-Toledo International Inc. (NYSE: MTD), a leader in precision instruments and services, stands as a significant player in the healthcare sector, specializing in diagnostics and research...

GSK plc (GSK) Stock Analysis: A Healthcare Giant with a 6.76% Potential Upside

For investors seeking opportunities in the healthcare sector, GSK plc (GSK) presents an intriguing proposition. As a prominent player in the drug manufacturing industry with a..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: A 40% Upside Potential Backed by Strong Buy Ratings

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable player within the healthcare sector, specifically in the diagnostics and research industry. With a robust market..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Hologic, Inc. (HOLX) Investor Outlook: Navigating Growth in the Medical Instruments Sector

Hologic, Inc. (NASDAQ: HOLX), a leader in the healthcare sector specializing in medical instruments and supplies, presents an intriguing case for investors focused on the intersection..

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating Growth and 15% Upside Potential

HCA Healthcare, Inc. (NYSE: HCA), a stalwart in the healthcare sector, offers investors a compelling opportunity with a market capitalization of $105.52 billion. Despite a recent..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 35% Upside Potential Amidst Strong Revenue Growth

Investors eyeing the healthcare sector may find GE HealthCare Technologies Inc. (NYSE: GEHC) an intriguing opportunity. With a substantial market capitalization of $31.59 billion, GE HealthCare..

AbbVie Inc. (ABBV) Stock Analysis: Unveiling a Potential 18.98% Upside Amid Robust Dividend Yield

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor attention with its promising growth potential and solid dividend yield. With a..

West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Powerhouse with a 30% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a key player in the healthcare sector, specifically within the medical instruments and supplies industry. With a robust..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 12% Potential Upside Amidst Market Fluctuations

Biogen Inc. (BIIB), a significant player in the healthcare sector, particularly in the drug manufacturing industry, has been navigating a dynamic market landscape. With a market..

Veeva Systems Inc. (VEEV) Stock Analysis: A Potential 56.98% Upside Amidst Healthcare Tech Expansion

Veeva Systems Inc. (NYSE: VEEV) stands as a formidable player in the healthcare technology sector, offering a comprehensive suite of cloud-based software solutions tailored to the..

CVS Health Corporation (CVS) Stock Analysis: Robust Buy Ratings and a Potential 37.7% Upside Captivate Investors

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, presents a compelling investment opportunity marked by strong analyst endorsements and substantial growth potential. With..

Regeneron Pharmaceuticals (REGN): Investor Outlook with a Promising 18% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands out in the biotechnology sector with a robust market capitalization of $77.99 billion, reflecting its significant influence and stature in..

Johnson & Johnson (JNJ)

⚠️ No article content returned.

..

Gilead Sciences, Inc. (GILD) Investor Outlook: Exploring a 17.27% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a stalwart in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic collaborations. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds